Better Therapeutics (BTTX) Competitors $0.0001 0.00 (0.00%) (As of 12/20/2024 02:47 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends BTTX vs. UPHL, ACONW, AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. Better Therapeutics vs. UpHealth Aclarion American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings. Does the MarketBeat Community believe in BTTX or UPHL? Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users. CompanyUnderperformOutperformBetter TherapeuticsOutperform Votes541.67% Underperform Votes758.33% UpHealthN/AN/A Is BTTX or UPHL more profitable? UpHealth's return on equity of 34.37% beat Better Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Better TherapeuticsN/A N/A N/A UpHealth N/A 34.37%9.54% Do institutionals and insiders believe in BTTX or UPHL? 34.0% of Better Therapeutics shares are held by institutional investors. Comparatively, 56.1% of UpHealth shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Comparatively, 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, BTTX or UPHL? Better Therapeutics has a beta of 1.9, indicating that its stock price is 90% more volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Which has preferable earnings & valuation, BTTX or UPHL? Better Therapeutics has higher earnings, but lower revenue than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than Better Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBetter TherapeuticsN/AN/A-$39.76M-$1.150.00UpHealth$130M0.00-$56.42M-$1.350.00 Does the media refer more to BTTX or UPHL? In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score. Company Overall Sentiment Better Therapeutics Neutral UpHealth Neutral SummaryBetter Therapeutics beats UpHealth on 6 of the 10 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$867.07M$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E Ratio0.0032.2090.1317.19Price / SalesN/A3.751,116.25117.05Price / CashN/A25.1443.1037.85Price / Book0.002.924.784.78Net Income-$39.76M-$5.79M$120.31M$225.60M7 Day PerformanceN/A-4.93%-1.92%-1.23%1 Month PerformanceN/A-5.95%13.65%0.46%1 Year PerformanceN/A218.58%28.34%15.24% Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/A$0.00flatN/A-99.9%$5,000.00N/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.8%$6,000.00$130M0.001,750Gap UpHigh Trading VolumeACONWAclarionN/A$0.03-17.9%N/A-36.1%$0.00$49,289.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$4.68+2.7%N/A-22.5%$0.00$1.34B0.001,520News CoverageDHACWDigital Health AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$1.05-16.7%N/A+15.4%$0.00$196.12M0.001,202LFMDPLifeMDN/A$22.500.0%N/A+17.1%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-3.5%N/A-57.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-15.5%N/AN/A$0.00$1.48B0.00500Positive NewsGap UpTALKWTalkspaceN/A$0.12-11.9%N/A+7.1%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01-3.8%N/A-95.0%$0.00$378.93M0.00660Positive News Related Companies and Tools Related Companies UPHL Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives CORBF Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BTTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
